We, the selling shareholders, and Citigroup Global Markets Inc. as underwriter named below, plan to enter into an underwriting agreement with respect to the ordinary shares being offered. Subject to the terms and conditions contained in the underwriting agreement, each selling shareholder has agreed to sell to the underwriter, and the underwriter has agreed to purchase at the price set forth on the cover page of this prospectus supplement, the ordinary shares.
The underwriting agreement provides that the obligations of the underwriter to purchase from each selling shareholder the ordinary shares offered hereby are subject to the satisfaction of certain conditions precedent and that the underwriter will purchase all of the ordinary shares offered by this prospectus supplement.
We and each selling shareholder have agreed for a period of 30 days from the date of this prospectus supplement that we and they will not, without the prior written consent of the underwriter, (i) directly or indirectly, offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, or otherwise transfer or dispose of any ordinary shares or any securities convertible into or exercisable or exchangeable for any ordinary shares or file any registration statement under the Securities Act of 1933 with respect to any of the foregoing or (ii) enter into any swap or any other agreement or any transaction that transfers, in whole or in part, directly or indirectly, the economic consequence of ownership of any ordinary shares, whether any such swap or transaction described in clause (i) or (ii) above is to be settled by delivery of any ordinary shares or such other securities, in cash or otherwise.
Our officers and directors have agreed for a period of 30 days from the date of this prospectus supplement that we and they will not, without the prior written consent of the underwriter, (i) directly or indirectly, offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, or otherwise transfer or dispose of any ordinary shares or any securities convertible into or exercisable or exchangeable for any ordinary shares or file any registration statement under the Securities Act of 1933 with respect to any of the foregoing, or (ii) enter into any swap or any other agreement or any transaction that transfers, in whole or in part, directly or indirectly, the economic consequence of ownership of any ordinary shares, whether any such swap or transaction described in clause (i) or (ii) above is to be settled by delivery of any ordinary shares or such other securities, in cash or otherwise, (iii) make any demand or exercise any right or cause to be filed a registration statement, including any amendments thereto, with respect to the registration of any ordinary shares or securities convertible into or exercisable or exchangeable for ordinary shares or any other of our securities, or (iv) publicly disclose the intention to do any of the foregoing.
The underwriter proposes to offer the shares for sale from time to time in or more transactions on Nasdaq, in the over-the-counter market, through negotiated transactions or otherwise at market prices prevailing at the time of sale, at prices related to prevailing market prices or at negotiated prices, subject to receipt of acceptance by it and subject to its right to reject any order in whole or in part. The underwriter may effect such transactions by selling the shares of ordinary shares to, or through, dealers, and such dealers may receive compensation in the form of discounts, concessions or commissions from the underwriter and/or purchasers of shares of ordinary shares for whom they may act as agents or to whom they may sell as principal. The difference between the price at which the underwriter purchases shares of ordinary shares, as set forth on the cover of this Prospectus Supplement, and the prices at which the underwriter resells such shares of ordinary shares may be deemed underwriting compensation.
Certain of our officers and directors may purchase our ordinary shares in this offering directly from the underwriter.
We estimate that the total expenses of this offering, excluding underwriting discounts and commissions, will be approximately $ million.
We and each selling shareholder have agreed to indemnify the underwriter against certain liabilities, including liabilities under the Securities Act of 1933. We have also agreed to pay for certain expenses in connection with this offering, including the fees and expenses of counsel to the underwriter.
The underwriter and certain of its affiliates are full service financial institutions engaged in various activities, which may include securities trading, commercial and investment banking, financial advisory, investment management, investment research, principal investment, hedging, financing and brokerage activities.